Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study

Breast Cancer Research and Treatment

Volumn 133, Issue 3, 2012, Pages 1143-1152

  Son, Byung Ho ^a   Ahn, Sei Hyun ^a   Kim, Sung Won ^b   Kang, Eunyoung ^b   Park, Sue K ^c   Lee, Min Hyuk ^d   Noh, Woo Chul ^e   Kim, Lee Su ^f   Jung, Yongsik ^g   Kim, Ku Sang ^g   Noh, Dong Young ^c   Moon, Byung In ^h   Suh, Young Jin ⁱ   Lee, Jeong Eon ^j   Choi, Doo Ho ^j   Kim, Sung Yong ^d   Jung, Sung Hoo ^k   Yom, Cha Kyong ^b   Lee, Hyde ^l   Yang, Jung Hyun ^m  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Soonchunhyang University   (South Korea)

^e Korea Cancer Center Hospital   (South Korea)

^f Hallym University   (South Korea)

^g Ajou University Medical Center   (South Korea)

^h Ewha Womans University   (South Korea)

ⁱ The Catholic University of Korea   (South Korea)

^j Sungkyunkwan University   (South Korea)

^k Chonbuk National University Medical School   (South Korea)

^l Yonsei University College of Medicine   (South Korea)

^m Konkuk University Hospital   (South Korea)

more..

Author keywords

BRCA1; BRCA2; Hereditary breast cancer; Korean; Non familial; Prevalence

Indexed keywords

ADENINE; CYTOSINE; THYMINE;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FAMILIAL CANCER; FEMALE; FLUORESCENCE ANALYSIS; GEL ELECTROPHORESIS; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC PREDISPOSITION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE BREAST; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE ORGAN CANCER; MUTATIONAL ANALYSIS; ONSET AGE; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOUTH KOREA; TUMOR SUPPRESSOR GENE;

ADULT; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; FOUNDER EFFECT; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PREVALENCE; REPUBLIC OF KOREA; YOUNG ADULT;

EID: 84863718506     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2001-0     Document Type: Article

References (46)

1. Schwartz GF, Hughes KS, Lynch HT et al (2008) Proceedings of the international consensus conference onbreast cancer risk, genetics, & risk management, April, 2007. Cancer 113:2627-2637
2. Brose MS, Rebbeck TR, Calzone KA et al (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94:1365-1372
3. Easton DF, Bishop DT, Ford D et al (1993) Genetic linkage analysis in familial breast and ovarian cancer: result from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52:678-701
4. King MC, Marks JH, Mandel JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646
5. Honrado E, Osorio A, Palacios J et al (2006) Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 25:5837-5845
6. Foulkes WD, Stefansson IM, Chappuis PO et al (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95:1482-1485
7. Liede A, Karlan BY, Narod SA (2004) Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 22:735-742
8. Robson ME (2007) Treatment of hereditary breast cancer. Semin Oncol 34:384-391
9. Wainberg S, Husted J (2004) Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiol Biomarkers Prev 13:1989-1995
10. Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656-1663
11. Clinical Practice Guidelines in Oncology (2010) Genetic/familial high risk assessment: breast and ovarian cancer. 2010. National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician- gls/PDF/genetics- screening.pdf. Accessed 20 Dec 2010
12. Balmaña J, Diez O, Rubio I et al (2010) BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol 21(supple):v20-v22
13. Lee JA, Kim KI, Bae JW et al (2010) Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival. Breast Cancer Res Treat 123:177-187
14. Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439-448
15. Son BH, Kwak BS, Kim JK et al (2006) Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg 141:155-160
16. Ahn SH, Yoo KY, The Korean Breast Cancer Society (2006) Chronological changes of clinical characteristics in 31, 115 new breast cancer patients among Koreans during 1996-2004. Breast Cancer Res Treat 99:209-214
17. American Cancer Society (2009) Breast Cancer Facts and Figures 2009-2010. American Cancer Society, Inc., Atlanta
18. Weitzel JN, Lagos VI, Gullinane CA et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297:2587-2595
19. Nagy R, Sweet K, Eng C (2004) Highly penetrant hereditary cancer syndromes. Oncogene 23:6445-6470
20. Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20:413-424
21. Neuhausen SL (2000) Founder populations and their uses for breast cancer genetics. Breast Cancer Res 2:77-81
22. Oh JH, Noh DY, Choe KJ et al (1995) Germline mutation of BRCA1 gene in Korean breast and ovarian cancer patients. J Korean Cancer Assoc 27:1061-1069
23. Kang HC, Kim IJ, Park JH et al (2002) Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families. Hum Mutat 20:235-239
24. Choi DH, Lee MH, Bale AE et al (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22:1638-1645
25. Seo JH, Cho DY, Ahn SH et al (2004) BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. Hum Mutat 24:350
26. Ahn SH, Hwang UK, Kwak BS et al (2004) Prevalence of BRCA1 and BRCA2 Mutations in Korean Breast Cancer Patients. J Korean Med Sci 19:269-274
27. Ahn SH, Son BH, Yoon KS et al (2007) BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Lett 8(245):90-95
28. Han SH, Lee KR, Lee DG et al (2006) Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Clin Genet 70:496-501
29. Kim BY, Lee DG, Lee KR et al (2006) Identification of BRCA1 and BRCA2 mutations from Korean breast cancer patients using denaturing HPLC. Biochem Biophys Res Commun 349:604-610
30. Kim TJ, Lee KM, Choi CH et al (2006) Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families. Oncol Rep 15:565-569
31. Kim EK, Kim KS, Park SK et al (2007) The Korean Hereditary Breast Cancer (KOHBRA) Study: protocol review. J Breast Cancer 10:241-247
32. Han SA, Park SK, Ahn SH et al (2011) The Korean Hereditary Breast Cancer (KOHBRA) Study: protocols and report. Clin Oncol (R Coll Radiol) 23(7):434-441
33. U.S. Preventive Services Task Force (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 5:355-361
34. Kurian AW (2010) BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 22:72-78
35. John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869-2876
36. Gershoni-Baruch R, Dagan E, Fried G et al (1999) BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer. Eur J Hum Genet 7:833-836
37. Rogozińska-Szczepka J, Utracka-Hutka B, Grzybowska E et al (2004) BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. Ann Oncol 15:1373-1376
38. Basham VM, Lipscombe JM, Ward JM et al (2002) BRCA1 and BRCA2 mutations in a population based study of male breast cancer. Breast Cancer Res 4:1-5
39. Couch FJ, Farid LM, Deshano ML et al (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13:123-125
40. Friedman LS, Gayther SA, Kurosaki T et al (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60:313-319
41. Mavraki E, Gray IC, Bishop T et al (1997) Germline BRCA2 mutations in men with breast cancer. Br J Cancer 76:1428-1431
42. Haraldsson K, Loman N, Zhang OX et al (1998) BRCA2 germline mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res 58:1367-1371
43. Csokay B, Udvarhelyi N, Sulyok Z et al (1999) High frequency of germline BRCA2 mutations among Hungarian male breast cancer patients without a family history. Cancer Res 59:995-998
44. Ding YC, Steele L, Kuan CJ et al (2011) Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res Treat 126:771-778
45. Kim YT, Nam EJ, Yoon BS et al (2005) Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma. Gynecol Oncol 99:585-590
46. Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10, 000 individuals. J Clin Oncol 20:1480-1490